Lung Cancer (Diagnosis)Digital healthBehavioralBehavioral
What this study is
The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.
What's being tested
- High Touch Outreach
Intervention · BEHAVIORAL
Gain-framed message, informational flyer, and direct request
Study details
- Official title
- Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Conditions
- Lung Cancer (Diagnosis) · Anxiety · Depression in Adults
- Enrolling
- 30 people
- Starts
- 2025-08-18
- Est. completion
- 2027-06-30
- Design
- Double-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Are aged 18 years or older.
- Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.
- Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.
You can't join if
- Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC).
- Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openAbramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Alexandria Muench, PsyD · Contact215-421-4491amuench@pennmedicine.upenn.edu
- Courtney Wolk, PhD · Sub-investigator
- Matthew Press, MD, MSc · Sub-investigator
- Aditi Singh, MD · Sub-investigator
- Faith Mutale, CRNP · Sub-investigator
- Katharine Rendle, PhD, MSW · Sub-investigator
- Anil Vachani, MD, MS · Sub-investigator
- Kristin Linn, PhD · Sub-investigator
- Eleanor Anderson, MD · Sub-investigator
- Tiffany Hogan, MA, CCC-SLP · Sub-investigator
Recruiting
Study team
Sponsor
Abramson Cancer Center at Penn Medicine
Study ID UPCC 31524
Principal investigator
Alexandria Muench, PsyD
University of Pennsylvania
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.